VINDICO NANOBIOTECHNOLOGY, INC.

Basic Information

A169, ASTeCC Bldg.,145 Graham Avenue
LEXINGTON, KY, 40506-0286

http://vindicopharma.com

Company Profile

n/a

Additional Details

Field Value
DUNS: 808379072
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 3


  1. A transfollicular nanovaccine against leishmaniasis

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): The World Health Organization estimates that over 350 million people are at risk of developing leishmaniasis and infection prevalence is 14 million people in the w ...

    SBIR Phase I 2011 Department of Health and Human Services
  2. Modulation of In Vivo Tumor Oxygenation via Polymersome-encapsulated Myoglobin

    Amount: $299,888.00

    DESCRIPTION (provided by applicant): Over 250,000 new cases of head and neck cancers (HNCs) and non-small cell lung cancers (NSCLCs) are diagnosed every year in the United States. At the time of diagn ...

    SBIR Phase I 2011 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government